Fundraising Fox
/Companies
Sign in

Qpex Biopharma

San Diego, US · Founded 2018 · 36 employees on LinkedIn · 4 known investors

Find your way into Qpex Biopharma

Sign up to see every warm intro you have to Qpex Biopharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Qpex Biopharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria. The company operates R&D laboratories in San Diego, California, working alongside Shionogi's research labs in Japan.

BiotechHealthtech

Founders & leadership

Qpex Biopharma was founded in 2018 by Michael N. Dudley.

MNMichael N. Dudley
Michael N. DudleyFounder · Strategic Advisor
TG
Terry GouldNamed on SEC filing
DB
Daniel BurgessNamed on SEC filing

Board

CGCarol Gallagher
Carol GallagherBoard directorAdvisor at New Enterprise Associates (NEA)
DRDouglas Reed
Douglas ReedBoard directorGeneral Partner at Hatteras Venture Partners
KLKevin Li
Kevin LiBoard directorManaging Partner at LYZZ Capital

Investors · 4

LYZZ Capitallisted by LYZZ CapitalShanghai

How we know: funding news · Not right? Tell us

New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M

How we know: a partner's Signal profile · funding news · Not right? Tell us

Adams Street PartnersreportedChicago · $150M – $750M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$27.4M disclosed across 1 round · 2018

▶$27.4MraisedAug 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael N. DudleyExecutive Officer, Director
  • Carol GallagherDirector
  • Terry GouldDirector
  • Douglas ReedDirector
  • Kevin LiDirector
  • Daniel BurgessDirector
Offering amount
$41.1M
Amount sold
$27.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Qpex Biopharma.

Frequently asked questions

What does Qpex Biopharma do?
QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria. The company operates R&D laboratories in San Diego, California, working alongside Shionogi's research labs in Japan.
Who founded Qpex Biopharma?
Qpex Biopharma was founded by Michael N. Dudley in 2018.
Who are Qpex Biopharma's investors?
Qpex Biopharma's investors include Hatteras Venture Partners, LYZZ Capital, New Enterprise Associates (NEA), Adams Street Partners.
How much funding has Qpex Biopharma raised?
Qpex Biopharma has disclosed $27.4M raised across 1 round.
Where is Qpex Biopharma headquartered?
Qpex Biopharma is headquartered in San Diego, US.